← Evidence map

ArticleOncotarget2016

Therapeutic siRNA for drug-resistant HER2-positive breast cancer.

Shenda Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26894975